PROSTATIC CANCER

Clinical trials for PROSTATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new PROSTATIC CANCER trials appear

Sign up with your email to follow new studies for PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 1 Terminated 1

Experimental cancer drug trial halted early

Disease control Terminated

This study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…

Matched conditions: PROSTATIC CANCER

Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control

Last updated May 04, 2026 16:31 UTC

PROSTATIC CANCER

Get alerted when new PROSTATIC CANCER trials appear

Experimental cancer drug trial halted early